Promoting innovative neurotechnology ideas for diverse communities
Official title: Outreach
Funded at Johns Hopkins University · NIH-10919815 · Data updated 2026-11-12
This study is all about finding new technology to help people with mental health issues, aging concerns, and neurological disorders, especially those from underserved communities, by listening to their needs and working with diverse innovators to create better solutions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 30, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $215,803 |
| NIH project number | 5U54EB033664-03 |
| Project ID | NIH-10919815 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals from underserved communities, particularly those affected by neurological disorders, mental health issues, and aging-related conditions.
✕Less likely to help
Patients who do not have access to neurotechnology solutions or are not part of the targeted underserved communities may not benefit from this research.
What this research studies
This research focuses on fostering an inclusive environment to identify and develop innovative neurotechnology solutions that address the needs of underserved populations. The project will conduct annual assessments to understand the specific needs of patients and communities, particularly in the areas of mental health, aging, and neurological disorders. By engaging with diverse innovators and advocacy groups, the initiative aims to create a pipeline for new technologies that can lead to better diagnostics and therapeutics. The outreach efforts will also include educational components to empower innovators from underrepresented backgrounds.
Why it matters
Potential benefit: If successful, this research could lead to the development of groundbreaking neurotechnology solutions that improve health outcomes for diverse and underserved patient populations.
How similar studies have gone: Previous initiatives focusing on inclusive innovation in healthcare have shown promise in improving access and outcomes for diverse populations, suggesting a positive outlook for this approach.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Nwulia, Evaristus a — Johns Hopkins University
- Study coordinator: Nwulia, Evaristus a
Related research
Other NIH-funded projects on the same topics.
-
Targeting hidden brain injuries in iTTP to improve long-term brain health
A researcher aims to find out how silent brain injuries in people with immune thrombotic thrombocytopenic purpura (iTTP) happen, how they affect thinking and stroke risk, and how to prevent them.
-
Accelerated flap coverage for severe leg injuries: earlier reconstruction vs standard timing
This study tests whether doing early flap coverage after a severe leg injury lowers infection risk and improves healing for patients with open wounds and bone injury.
-
Placebo-controlled shunting for iNPH: does the surgery help with walking and balance?
A doctor-led trial at Johns Hopkins will test whether a shunt surgery improves walking and balance in older adults with idiopathic normal pressure hydrocephalus.
-
Omalizumab for COPD patients with allergen sensitization and exposure
A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.
-
Johns Hopkins Total Worker Health Center focusing on mental health
A nationwide center at Johns Hopkins is working to improve mental health and well-being among workers by studying workplace health strategies and translating findings into practical tools.
-
Role of fat droplets in liver fat and inflammatory signals in NAFLD
A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.